In a recent market study, Fact.MR covers recent developments in the global constipation laxative market, highlighting vital aspects such as trends, drivers, opportunities, and restraints.
Retail Pharmacies to Account for 45% of the Constipation Laxative Revenue Share
In a recent market study, Fact.MR covers recent developments in the global constipation laxative market, highlighting vital aspects such as trends, drivers, opportunities, and restraints. The report studies recent developments in the segments of the market in terms of mode of mechanism, route of administration, distribution channel and region.
Fact.MR – A Market Research and Competitive Intelligence Provider:
The global constipation laxative market is expected to provide steady growth, expanding the market size at a CAGR of 5.7% by 2030. The market value of constipation laxative is set to achieve US$ 10.8 Bn by 2030.
Opioid Induced Constipation (OIC) is the most compelling side-effect of some drugs that impacts negatively during consumption adherence to analgesic prescriptions. OIC accounts for six out of ten non-cancer patients receiving opioids.
Various metabolic disorders are also responsible for constipation. non-diabetic patients are less susceptible to constipation than diabetic patients. Based on the aforementioned factors, the use of constipation laxatives has climbed up and will constantly grow in the future.
For Critical Insights On This Market, Request For More Info
https://www.factmr.com/connectus/sample?flag=S&rep_id=4801
Manufacturers are throwing their interest on research and development to launch new branded generic products to create enormous opportunities by targeting emerging economies.
Online sales platforms are resorted by some market players for marketing over-the-counter laxative brands. Less prominent players are concentrating on mergers and acquisitions in order to authorise market presence.
Rising adoption of sedentary lifestyles directed to a reduced intake of water by individuals in the wake of reduced physical activity. As a bottom line, incidence of constipation has increased across world. This is expected to burgeon market prospects in the future.
|
Report Attributes |
Values |
|
Market Size Value in 2019 |
US$ 5.9 Bn |
|
Projected Market Forecast Value by 2030 |
US$ 10.8 Bn |
|
Global Growth Rate (2019 to 2030) |
5.7% CAGR |
Key Takeaways:
- The maximum market share captured in Bulk-forming laxatives to anticipate accounting for over one-third of the global constipation laxatives market throughout the period.
- Bulk Forming was the largest segment by mode of mechanism in the constipation-laxative market in 2019, accounting for 36% of sales share.
- By route of administration, oral accounted for the highest revenue in 2019, and is expected to continue this constant trend throughout the period.
- Retail pharmacies accounted for a 45% revenue share due to their over-the-counter (OTC) product, which may be obtained by anyone suffering from an upset stomach, assisting the laxative market's expansion.
- North America and Europe are expected to provide 60% market share, with North America market size expanding at a CAGR of ~5.5% by 2030.
Growth drivers:
- The market for constipation laxatives to witness increased sales amongst the patients with existing chronic ailments such as diabetes, hypothyroidism and anorectal disorders.
- Increasing prevalence of constipation, growing awareness about gastrointestinal infections and increased support from the government to develop adequate healthcare infrastructure are some important factors driving market growth of constipation laxatives
To learn more about Constipation laxative Market, you can get in touch with our Analyst at
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4801
Competitive Landscape:
Less prominent players are speculating on mergers and acquisitions in order to authorize market presence. For instance
In 2018, Mallinckrodt Pharmaceuticals acquired Sucampo Pharmaceuticals to ascendancy their industry leading capabilities and R&D capabilities to accelerate innovation.
Key Players in the Constipation Laxative Market Include:
- GlaxoSmithKline
- Bayer AG, Sanofi
- Takeda
- Abbott Laboratories
- Purdue Pharma LP
More Valuable Insights on Constipation Laxative Market
Fact.MR provides an unbiased analysis of the constipation laxative market, presenting forecast statistics for the period from 2020-2030. The study divulges compelling insights on the global Constipation laxative market with a detailed segmentation on the basis of:
Mode of Mechanism
- Lubricant
- Bulk Forming
- Emollient(Stool softeners)
- Stimulant
- Saline Laxatives
- Hyperosmotic
- Others
Route of Administration
- Oral
- Rectal
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
Regions
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Explore Fact.MR’s Coverage on the Healthcare Domain –
Non-Invasive Ultrasound Stimulation Market Scope - The market for non-invasive ultrasound stimulation is being driven by the rising prevalence of neurological illnesses and the growing baby boomer demographic, both of which are linked to brain disorders.
Ultrasound Systems Market Forecast - Over the last few years, demand for ultrasound systems has continuously increased, with manufacturers responding by incorporating cutting-edge technologies. Ultrasound system vendors have seen substantial growth in the previous five years, thanks to developments in hospitals and diagnostic centres.
Endoscopy Ultrasound Market Analysis - Technological advancements and increased awareness are significant growth factors. Endoscopy ultrasound procedures cost much lesser than other techniques such as Endoscopic Retrograde Cholangiopancreatography (ERCP). The global market has benefited as a result of these reasons
Non-Invasive Ultrasound Stimulation Market Trends - The market for non-invasive ultrasound stimulation is being driven by the rising prevalence of neurological illnesses and the growing baby boomer demographic, both of which are linked to brain disorders
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR